Skip to main content

Asymmetries and visual field summaries as predictors of glaucoma in the ocular hypertension treatment study.

Publication ,  Journal Article
Levine, RA; Demirel, S; Fan, J; Keltner, JL; Johnson, CA; Kass, MA; Ocular Hypertension Treatment Study Group
Published in: Invest Ophthalmol Vis Sci
September 2006

PURPOSE: To evaluate whether baseline visual field data and asymmetries between eyes predict the onset of primary open-angle glaucoma (POAG) in Ocular Hypertension Treatment Study (OHTS) participants. METHODS: A new index, mean prognosis (MP), was designed for optimal combination of visual field thresholds, to discriminate between eyes that developed POAG from eyes that did not. Baseline intraocular pressure (IOP) in fellow eyes was used to construct measures of IOP asymmetry. Age-adjusted baseline thresholds were used to develop indicators of visual field asymmetry and summary measures of visual field defects. Marginal multivariate failure time models were constructed that relate the new index MP, IOP asymmetry, and visual field asymmetry to POAG onset for OHTS participants. RESULTS: The marginal multivariate failure time analysis showed that the MP index is significantly related to POAG onset (P < 0.0001) and appears to be a more highly significant predictor of POAG onset than either mean deviation (MD; P = 0.17) or pattern standard deviation (PSD; P = 0.046). A 1-mm Hg increase in IOP asymmetry between fellow eyes is associated with a 17% increase in risk for development of POAG. When threshold asymmetry between eyes existed, the eye with lower thresholds was at a 37% greater risk of development of POAG, and this feature was more predictive of POAG onset than the visual field index MD, though not as strong a predictor as PSD. CONCLUSIONS: The MP index, IOP asymmetry, and binocular test point asymmetry can assist in clinical evaluation of eyes at risk of development of POAG.

Duke Scholars

Published In

Invest Ophthalmol Vis Sci

DOI

ISSN

0146-0404

Publication Date

September 2006

Volume

47

Issue

9

Start / End Page

3896 / 3903

Location

United States

Related Subject Headings

  • Visual Fields
  • Visual Field Tests
  • Vision Disorders
  • Time Factors
  • Risk Factors
  • Prognosis
  • Ophthalmology & Optometry
  • Ocular Hypertension
  • Middle Aged
  • Male
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Levine, R. A., Demirel, S., Fan, J., Keltner, J. L., Johnson, C. A., Kass, M. A., & Ocular Hypertension Treatment Study Group. (2006). Asymmetries and visual field summaries as predictors of glaucoma in the ocular hypertension treatment study. Invest Ophthalmol Vis Sci, 47(9), 3896–3903. https://doi.org/10.1167/iovs.05-0469
Levine, Richard A., Shaban Demirel, Juanjuan Fan, John L. Keltner, Chris A. Johnson, Michael A. Kass, and Ocular Hypertension Treatment Study Group. “Asymmetries and visual field summaries as predictors of glaucoma in the ocular hypertension treatment study.Invest Ophthalmol Vis Sci 47, no. 9 (September 2006): 3896–3903. https://doi.org/10.1167/iovs.05-0469.
Levine RA, Demirel S, Fan J, Keltner JL, Johnson CA, Kass MA, et al. Asymmetries and visual field summaries as predictors of glaucoma in the ocular hypertension treatment study. Invest Ophthalmol Vis Sci. 2006 Sep;47(9):3896–903.
Levine, Richard A., et al. “Asymmetries and visual field summaries as predictors of glaucoma in the ocular hypertension treatment study.Invest Ophthalmol Vis Sci, vol. 47, no. 9, Sept. 2006, pp. 3896–903. Pubmed, doi:10.1167/iovs.05-0469.
Levine RA, Demirel S, Fan J, Keltner JL, Johnson CA, Kass MA, Ocular Hypertension Treatment Study Group. Asymmetries and visual field summaries as predictors of glaucoma in the ocular hypertension treatment study. Invest Ophthalmol Vis Sci. 2006 Sep;47(9):3896–3903.

Published In

Invest Ophthalmol Vis Sci

DOI

ISSN

0146-0404

Publication Date

September 2006

Volume

47

Issue

9

Start / End Page

3896 / 3903

Location

United States

Related Subject Headings

  • Visual Fields
  • Visual Field Tests
  • Vision Disorders
  • Time Factors
  • Risk Factors
  • Prognosis
  • Ophthalmology & Optometry
  • Ocular Hypertension
  • Middle Aged
  • Male